The Affiliated Hospital Of Xuzhou Medical University

This study tested whether giving evolocumab, a powerful cholesterol-lowering drug, within 24 hours after clot-busting treatment could prevent early neurological decline in people with acute ischemic stroke caused by large artery atherosclerosis. 132 adults were randomly assigned …

This study tested whether giving a powerful cholesterol-lowering drug (evolocumab) within 6 hours after a stroke clot removal procedure could prevent early neurological worsening. 60 adults with large-vessel stroke were randomly assigned to receive either the drug plus standard c…